[1]
J. Pedro do Valle Varela, V. Lima Souza de Freitas, G. Silva Pereira, H. Volponi Pessoti, and J. Pedro de Morais Siqueira, “NEUROBIOLOGICAL IMPLICATIONS OF CRISPR/CAS 9 GENE EDITING IN THE TREATMENT OF NEURODEGENERATIVE DISEASES”, EASN, vol. 18, Aug. 2024, doi: 10.51249/easn18.2024.2173.